Nonresponder does not mean not better: Improvement in nonsymptom domains in complex depressed patients who are not symptomatic responders to intensive treatment.

Psychiatry Res

Department of Psychiatry and Human Behavior, Brown Medical School, Rhode Island Hospital, Providence, RI, United States.

Published: May 2023

AI Article Synopsis

  • In depression treatment studies, success is often measured by a 50% reduction in symptom severity, but many patients prioritize improved functioning and quality of life instead.
  • A study involving 844 patients with major depressive disorder used a questionnaire to evaluate how patients assess treatment outcomes beyond just symptom relief.
  • Even patients labeled as nonresponders in terms of symptom reduction showed significant improvements in nonsymptom areas, with about one-third achieving positive results in at least one of those domains.

Article Abstract

In treatment studies of depression, response is typically defined as a 50% or greater reduction in symptom severity. However, multiple surveys of depressed patients have found that patients prioritize improved functioning and quality of life objectives over symptom improvement as the most important goal of treatment. The goal of the present study is to widen the lens of assessing outcome by examining response in nonsymptom domains in patients who are, by convention, considered nonresponders to treatment. Eight hundred and forty-four patients with major depressive disorder completed the Remission from Depression Questionnaire (RDQ), a self-report measure that assesses multiple constructs considered by patients to be relevant to assessing treatment outcome. At discharge, the patients made a global rating of the effectiveness of treatment. The 517 patients who were nonresponders on the depression symptom subscale of the RDQ are the focus of this report. The patients showed significant levels of improvement from admission to discharge in all nonsymptom domains, with medium to large effect sizes. Approximately one-third of the patients were responders on at least 1 of the nonsymptom domains. The failure to meet the conventional definition of treatment response based on symptom severity does not preclude significant improvement in nonsymptom domains.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2023.115162DOI Listing

Publication Analysis

Top Keywords

nonsymptom domains
20
patients
10
improvement nonsymptom
8
depressed patients
8
symptom severity
8
treatment
7
nonsymptom
5
domains
5
nonresponder better
4
improvement
4

Similar Publications

Better than we think: Is the treatment of depressed patients more effective than we think?

Ann Clin Psychiatry

August 2023

Department of Psychiatry and Human Behavior, Brown Medical School, Rhode Island Hospital, Providence, Rhode Island, USA.

Article Synopsis
  • Many patients with major depressive disorder feel they have benefited from treatment, even if not classified as "responders" based on traditional symptom severity measures.
  • In a study involving 854 patients, less than 40% were deemed responders based solely on depression symptoms, but about two-thirds reported improvements in their overall well-being.
  • Findings indicate a need for patient-centered evaluation methods that consider various aspects of recovery, suggesting that treatment impacts go beyond just symptom reduction.
View Article and Find Full Text PDF
Article Synopsis
  • In depression treatment studies, success is often measured by a 50% reduction in symptom severity, but many patients prioritize improved functioning and quality of life instead.
  • A study involving 844 patients with major depressive disorder used a questionnaire to evaluate how patients assess treatment outcomes beyond just symptom relief.
  • Even patients labeled as nonresponders in terms of symptom reduction showed significant improvements in nonsymptom areas, with about one-third achieving positive results in at least one of those domains.
View Article and Find Full Text PDF

Measurement-based care (MBC) improves patient outcomes. However, there has been minimal focus on MBC for psychotic disorders. This study examines the use of patient-reported outcome measures (PROMs) in the Veterans Health Administration (VHA) to characterize their use among Veterans with psychotic disorders and to inform candidate measures for psychosis-related MBC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!